Tarsus commercial chief holds 14,800 shares
Four RSU awards have vesting dates from March 15, 2027, through March 15, 2030, subject to continuous service.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Tarsus Pharmaceuticals, Inc. (TARS) Chief Commercial Officer Neera Clase reported direct ownership of 14,800 common shares as of November 1, 2026. She also reported six stock-option positions covering 23,000, 18,701, 14,909, 9,119, 6,126 and 5,007 underlying shares, at respective exercise prices of $25.56, $19.59, $15.00, $35.50, $44.54 and $74.90. Four restricted stock unit awards cover 2,864, 3,080, 3,014 and 3,147 shares, with vesting schedules beginning March 15, 2027, subject to continuous service.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Clase Neera
Role
Chief Commercial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Option (right to buy) F1 | -- | -- | -- |
| Holding | Stock Option (right to buy) F2 | -- | -- | -- |
| Holding | Stock Option (right to buy) F3 | -- | -- | -- |
| Holding | Stock Option (right to buy) F4 | -- | -- | -- |
| Holding | Stock Option (right to buy) F5 | -- | -- | -- |
| Holding | Stock Option (right to buy) F6 | -- | -- | -- |
| Holding | Restricted Stock Units F7 | -- | -- | -- |
| Holding | Restricted Stock Units F8 | -- | -- | -- |
| Holding | Restricted Stock Units F9 | -- | -- | -- |
| Holding | Restricted Stock Units F10 | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Holdings:
Stock Option (right to buy) — 76,862 contracts (Direct);
Restricted Stock Units — 12,105 contracts (Direct);
Common Stock — 14,800 shares (Direct)
Footnotes (10)
- F1. Options granted under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan (the "Plan"). 25% of the option shares vested and became exercisable on August 16, 2022, and 1/48th of the option shares vested each month thereafter for a period of 3 years.
- F2. Options granted under the Plan. 25% of the option shares vested and became exercisable on March 9, 2023, and 1/48th of the option shares each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service.
- F3. Options granted under the Plan. 25% of the option shares vested and became exercisable on March 8, 2024, and 1/48th of the option shares each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service.
- F4. Options granted under the Plan. 25% of the option shares vested and became exercisable on March 7, 2025, and 1/48th of the option shares each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service.
- F5. Options granted under the Plan. 25% of the option shares vested and became exercisable on March 5, 2026, and 1/48th of the option shares each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service.
- F6. Options granted under the Plan. 25% of the option shares will vest and become exercisable on March 5, 2027, and 1/48th of the option shares each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service.
- F7. Restricted Stock Units ("RSUs") granted under the Plan. The RSUs shall vest on March 15, 2027, subject to the Reporting Person's continuous service.
- F8. RSUs granted under the Plan. The RSUs shall vest in equal annual installments on March 15, 2027 and March 15, 2028, subject to the Reporting Person's continuous service.
- F9. RSUs granted under the Plan. The RSUs shall vest in equal annual installments on March 15th of each of 2027, 2028, and 2029, subject to the Reporting Person's continuous service.
- F10. RSUs granted under the Plan. The RSUs shall vest in equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service.
Key Figures
Direct common shares: 14,800 shares
Underlying shares in stock options: 23,000 shares
Underlying shares in stock options: 18,701 shares
+5 more
8 metrics
Direct common shares
14,800 shares
Reported as of November 1, 2026
Underlying shares in stock options
23,000 shares
Exercise price $25.56; expiration September 6, 2031
Underlying shares in stock options
18,701 shares
Exercise price $19.59; expiration March 8, 2032
Underlying shares in stock options
14,909 shares
Exercise price $15.00; expiration March 7, 2033
Underlying shares in stock options
9,119 shares
Exercise price $35.50; expiration March 6, 2034
Underlying shares in stock options
6,126 shares
Exercise price $44.54; expiration March 4, 2035
Underlying shares in stock options
5,007 shares
Exercise price $74.90; expiration March 4, 2036
Restricted stock units
2,864, 3,080, 3,014 and 3,147 shares
Four awards; vesting subject to continuous service
Key Terms
Stock Option (right to buy), Restricted Stock Units, vested and became exercisable, continuous service
4 terms
Stock Option (right to buy) financial
"Stock Option (right to buy)"
Restricted Stock Units financial
"Restricted Stock Units granted under the Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vested and became exercisable financial
"25% of the option shares vested and became exercisable"
continuous service financial
"subject to the Reporting Person's continuous service"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When do Neera Clase’s TARS RSUs vest?
Her 2,864 RSUs vest on March 15, 2027; 3,080 RSUs vest in equal annual installments on March 15, 2027 and March 15, 2028; 3,014 RSUs vest in equal annual installments on March 15 of 2027, 2028 and 2029; and 3,147 RSUs vest in equal annual installments on March 15 of 2027, 2028, 2029 and 2030, each subject to her continuous service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
